肽核酸,類肽和多肽定制合成服務(wù)以及肽核酸單體,類肽單體
普通會(huì)員
產(chǎn)品價(jià)格面議
產(chǎn)品品牌賽曼諾生物
最小起訂≥5 mg
供貨總量1000 mg
發(fā)貨期限自買家付款之日起 3 天內(nèi)發(fā)貨
瀏覽次數(shù)42
企業(yè)旺鋪http://cellmano.sjooo.com/
更新日期2015-02-06 13:44
會(huì)員級別:企業(yè)會(huì)員
已 繳 納:0.00 元保證金
我的勛章: [誠信檔案]
企業(yè)二維碼: 企業(yè)名稱加二維碼
品牌: |
賽曼諾生物 |
所在地: |
安徽 合肥市 |
起訂: |
≥5 mg |
供貨總量: |
1000 mg |
有效期至: |
長期有效 |
Neuromedin U-8 (porcine) | C54H78N16O10 | 1111.32 | 98395-75-6 | H-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
Neuromedin U-23 (rat) NMU-23 |
C124H180N34O31 | 2643.00 | 117505-80-3 | H-Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
Neuromedin U-25 (human) NMU-25 (human) |
C141H203N41O38 | 3080.42 | 312306-89-1 | H-Phe-Arg-Val-Asp-Glu-Glu-Phe-Gln-Ser-Pro-Phe-Ala-Ser-Gln-Ser-Arg-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
Neuromedin U-25 (porcine) | C144H217N43O37 | 3142.57 | 98395-76-7 | H-Phe-Lys-Val-Asp-Glu-Glu-Phe-Gln-Gly-Pro-Ile-Val-Ser-Gln-Asn-Arg-Arg-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
Neuronostatin-13 (human, canine, porcine) | C64H110N20O16 | 1415.70 | 1096485-24-3 | H-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Ala-NH2 |
Neuronostatin-13 (mouse, rat) | C65H112N20O17 | 1445.73 | H-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Thr-NH2 | |
Neuronostatin-19 (human, canine, porcine) | C90H151N29O25 | 2039.37 | H-Ala-Pro-Ser-Asp-Pro-Arg-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Ala-NH2 | |
Neuronostatin-19 (mouse, rat) | C91H153N29O26 | 2069.40 | H-Ala-Pro-Ser-Asp-Pro-Arg-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Thr-NH2 | |
Biotinyl-(Des-Bromo)-Neuropeptide B (1-23) (human) Biotinyl-DesBr-NPB-23 (human) |
C117H176N32O32S | 2574.95 | Biotinyl-Trp-Tyr-Lys-Pro-Ala-Ala-Gly-His-Ser-Ser-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu-OH | |
(Des-Bromo)-Neuropeptide B (1-23) (human) DesBr-NPB-23 (human) |
C107H162N30O30 | 2348.65 | 434897-64-0 | H-Trp-Tyr-Lys-Pro-Ala-Ala-Gly-His-Ser-Ser-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu-OH |
Neuropeptide FF F-8-F-NH2, NPFF, F-8-F-amide |
C54H76N14O10 | 1081.29 | 99566-27-5 | H-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 |
(D-Tyr1,N-Me-Phe3)-Neuropeptide FF | C55H78N14O11 | 1111.31 | 145274-93-7 | H-D-Tyr-Leu-N-Me-Phe-Gln-Pro-Gln-Arg-Phe-NH2 |
RF9 | C26H38N6O3 | 482.63 | 876310-60-0 | 1-Adamantanecarbonyl-Arg-Phe-NH2 |
Neuropeptide S (1-10) (human) | C42H68N14O14S | 1025.15 | 904910-39-0 | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-OH |
Neuropeptide S (human) NPS (human) |
C93H155N31O28S | 2187.51 | 412938-67-1 | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser-OH |
Neuropeptide S (rat) NPS (rat) |
C95H160N34O27 | 2210.53 | 412938-75-1 | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Ser-Gly-Val-Lys-Lys-Thr-Ser-Phe-Arg-Arg-Ala-Lys-Gln-OH |
Neuropeptide W-23 (human) NPW-23 (human) |
C119H183N35O28S | 2584.05 | 383415-79-0 | H-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-OH |
Biotinyl-Neuropeptide W-23 (human) Biotinyl-NPW-23 (human) |
C129H197N37O30S2 | 2810.35 | Biotinyl-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-OH | |
Neuropeptide W-23 (rat) rPPL8 (42-64), Preproprotein L8 (42-64) (rat), rL8, NPW-23 (rat) |
C119H183N35O29S | 2600.05 | 383415-89-2 | H-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Met-Gly-Leu-OH |
Neuropeptide W-30 (human) NPW-30 (human), hPPL8 (33-62), Preproprotein L8 (33-62) (rat), hL8C |
C165H249N49O37S | 3543.17 | 383415-80-3 | H-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp-OH |
本網(wǎng)頁所展示的有關(guān)【DesBr-NPB-23 (human)_生化試劑_合肥賽曼諾生物科技有限公司】的信息/圖片/參數(shù)等由商一網(wǎng)的會(huì)員【合肥賽曼諾生物科技有限公司】提供,由商一網(wǎng)會(huì)員【合肥賽曼諾生物科技有限公司】自行對信息/圖片/參數(shù)等的真實(shí)性、準(zhǔn)確性和合法性負(fù)責(zé),本平臺(本網(wǎng)站)僅提供展示服務(wù),請謹(jǐn)慎交易,因交易而產(chǎn)生的法律關(guān)系及法律糾紛由您自行協(xié)商解決,本平臺(本網(wǎng)站)對此不承擔(dān)任何責(zé)任。您在本網(wǎng)頁可以瀏覽【DesBr-NPB-23 (human)_生化試劑_合肥賽曼諾生物科技有限公司】有關(guān)的信息/圖片/價(jià)格等及提供【DesBr-NPB-23 (human)_生化試劑_合肥賽曼諾生物科技有限公司】的商家公司簡介、聯(lián)系方式等信息。
在您的合法權(quán)益受到侵害時(shí),歡迎您向郵箱發(fā)送郵件,或者進(jìn)入《網(wǎng)站意見反饋》了解投訴處理流程,我們將竭誠為您服務(wù),感謝您對商一網(wǎng)的關(guān)注與支持!